Literature DB >> 18677141

Vaccines for pertussis and influenza: recommendations for use in pregnancy.

Stanley A Gall1.   

Abstract

The active immunization of pregnant women during pregnancy to protect them from disease and protect their neonate with passive antibodies is a biologic fact. Fortunately, many infectious diseases occur infrequently due to excellent pediatric vaccine programs. However, most adults and many physicians are unaware of the risks of not administering vaccines especially to pregnant women. Influenza vaccine (trivalent inactivated influenza vaccine) is recommended by (Advisory Committee on Immunization Practices (ACIP) for pregnant women in any trimester of pregnancy and Tetanus, reduced diphtheria, and pertussis (TdaP) vaccine is recommended by the ACIP to be given before pregnancy, during pregnancy, or in the immediate postpartum period. Only 2% of the adult US population is protected against pertussis and it is estimated that only 25% of pregnant women receive influenza vaccine during the influenza season. This chapter discusses trivalent inactivated influenza vaccine and TdaP use during pregnancy, the diseases they prevent, and the benefit to the neonate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677141     DOI: 10.1097/GRF.0b013e318181dde1

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

1.  Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels.

Authors:  Lourdes R A Vaz-de-Lima; Helena Keico Sato; Eder Gatti Fernandes; Ana Paula Sayuri Sato; Lucia C Pawloski; Maria Lucia Tondella; Cyro A de Brito; Expedito J A Luna; Telma Regina M P Carvalhanas; Euclides A de Castilho
Journal:  Vaccine       Date:  2019-05-29       Impact factor: 3.641

2.  Pertussis antibodies in postpartum women and their newborns.

Authors:  J H Shakib; S Ralston; H H Raissy; G J Stoddard; K M Edwards; C L Byington
Journal:  J Perinatol       Date:  2009-10-08       Impact factor: 2.521

3.  Cord blood antibodies following maternal coronavirus disease 2019 vaccination during pregnancy.

Authors:  Leena B Mithal; Sebastian Otero; Elisheva D Shanes; Jeffery A Goldstein; Emily S Miller
Journal:  Am J Obstet Gynecol       Date:  2021-04-01       Impact factor: 8.661

Review 4.  Current Challenges and Achievements in Maternal Immunization Research.

Authors:  Flor M Munoz
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.